AMPHIVENA THERAPEUTICS INC has a total of 39 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 2015. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals and biotechnology are HEIDELBERG IMMUNOTHERAPEUTICS GMBH, RADIMMUNE THERAPEUTICS INC and KINETA CHRONIC PAIN LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Australia | 3 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | Israel | 3 | |
#6 | Argentina | 2 | |
#7 | Brazil | 2 | |
#8 | Canada | 2 | |
#9 | China | 2 | |
#10 | Republic of Korea | 2 | |
#11 | Mexico | 2 | |
#12 | Singapore | 2 | |
#13 | Taiwan | 2 | |
#14 | Hong Kong | 1 | |
#15 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Guenot Jeanmarie | 26 |
#2 | Evnin Luke | 25 |
#3 | Kunkel Lori | 25 |
#4 | Weichel Michael | 15 |
#5 | Little Melvyn | 15 |
#6 | Wall Claudia | 15 |
#7 | Ellwanger Kristina | 15 |
#8 | Fox Judith A | 14 |
#9 | Zhukovsky Eugene | 14 |
#10 | Reusch Uwe | 14 |
Publication | Filing date | Title |
---|---|---|
WO2020243603A1 | Dosing of bispecific t cell engager | |
US2020262920A1 | Dosing regimen for cd3 binding proteins | |
WO2016196230A1 | Methods of using bispecific cd33 and cd3 binding proteins | |
US9212225B1 | Bispecific CD33 and CD3 Binding Proteins |